Cisplatin hearing monitoring
WebLatest version (submitted April 10, 2024) on ClinicalTrials.gov A study version is represented by a row in the table. Select two study versions to compare. One each from columns A and B. Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. WebNational Center for Biotechnology Information
Cisplatin hearing monitoring
Did you know?
WebSep 1, 2024 · Monitor patients receiving Cisplatin for injection for possible hypersensitivity reactions. Ensure supportive equipment and medications are available to treat severe … WebCisplatin can cause irreversible hearing loss initially detectable as impairment of high-frequency hearing with progression to lower frequencies. Many patients receiving …
WebJan 1, 2016 · Cisplatin is an effective drug used in the treatment of many cancers, yet its ototoxic potential places cancer patients, exposed to this drug, at risk of hearing loss, thus negatively impacting... WebJun 1, 2024 · Hearing loss is a side effect of one of the most common cancer treatments: cisplatin. Though effective at fighting most solid tumor cancers, the drug penetrates the …
WebAtorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer Latest version (submitted April 11, 2024) on ClinicalTrials.gov A study version is represented by a row in the table. Select two study versions to compare. One each from columns A and B. WebOct 20, 2024 · Cumulative dose of cisplatin is an important predictor of development of ototoxicity. Baseline and periodic audiometric monitoring could detect ototoxicity early which leads to possible...
WebFeb 11, 2024 · Cisplatin is a highly effective chemotherapeutic drug used against a wide range of childhood and adult cancers, but cisplatin crosses into the cochlea, which often results in permanent sensorineural cisplatin-induced hearing loss (CIHL).
WebApr 12, 2024 · In cancer patients treated with cisplatin, it would be of notable interest to include in the clinical routine the monitoring of Oct2 polymorphism, as the subjects carrying such polymorphism have a low risk to develop cisplatin-related AKI. For this reason, they would be the ideal candidates for such chemotherapy. raw dog food northamptonWebApr 5, 2024 · PDF. Figures and Tables. Ototoxicity is defined as damage to structures and function of the auditory-vestibular system caused by exogenous agents, such as … raw dog food ncWebMar 31, 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn … simple cornish hen brineWebNational Center for Biotechnology Information raw dog food new jerseyWebApr 17, 2024 · For patients treated with the chemotherapeutic drug cisplatin, one common consequence of treatment is permanent hearing loss. Reported rates of cisplatin ototoxicity vary widely, though it is believed that at least half of all patients treated with cisplatin will suffer hearing loss. simple corporate attire for women 2015WebMay 1, 2005 · Monitoring hearing in patients receiving ototoxic drugs provides audiologists opportunities to counsel patients and their families regarding ototoxicity-induced hearing … raw dog food north carolinaWebDescription; ABSTRACT. Background: The aim of this study is to evaluate the current state of ototoxicity monitoring for patients receiving cisplatin chemotherapy in an academic medical center with particular attention to how closely monitoring adheres to national ototoxicity guidelines.. Methods: Case series including retrospective medical records … simple cornrows for short natural hair